IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 153 filers reported holding IMMUNOVANT INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $428,841 | -33.2% | 16,244 | -18.3% | 0.00% | -50.0% |
| Q1 2024 | $642,226 | -16.1% | 19,877 | +9.4% | 0.00% | 0.0% |
| Q4 2023 | $765,671 | +28.2% | 18,174 | +16.8% | 0.00% | 0.0% |
| Q3 2023 | $597,119 | +103.7% | 15,554 | +0.6% | 0.00% | +100.0% |
| Q2 2023 | $293,182 | +32.5% | 15,455 | +8.4% | 0.00% | 0.0% |
| Q1 2023 | $221,204 | -24.1% | 14,262 | -13.1% | 0.00% | 0.0% |
| Q4 2022 | $291,260 | +264.1% | 16,409 | +15.4% | 0.00% | – |
| Q3 2022 | $80,000 | +50.9% | 14,223 | +4.9% | 0.00% | – |
| Q2 2022 | $53,000 | -50.9% | 13,564 | -31.0% | 0.00% | – |
| Q1 2022 | $108,000 | -49.1% | 19,654 | -21.2% | 0.00% | – |
| Q4 2021 | $212,000 | -17.8% | 24,955 | -16.0% | 0.00% | -100.0% |
| Q3 2021 | $258,000 | -10.7% | 29,701 | +8.7% | 0.00% | 0.0% |
| Q2 2021 | $289,000 | -23.5% | 27,335 | +15.9% | 0.00% | 0.0% |
| Q1 2021 | $378,000 | -65.1% | 23,577 | +0.7% | 0.00% | -75.0% |
| Q4 2020 | $1,082,000 | – | 23,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,000,200 | $26,072,000 | 5.92% |
| MANGROVE PARTNERS IM, LLC | 1,139,900 | $9,906,000 | 0.89% |
| Eventide Asset Management | 4,950,000 | $43,016,000 | 0.57% |
| Ghost Tree Capital, LLC | 200,000 | $1,738,000 | 0.51% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,221,000 | 0.47% |
| FRAZIER MANAGEMENT LLC | 585,759 | $5,090,000 | 0.41% |
| MANGROVE PARTNERS IM, LLC | 500,000 | $4,345,000 | 0.39% |
| EcoR1 Capital, LLC | 1,140,819 | $9,914,000 | 0.34% |
| BCK CAPITAL MANAGEMENT LP | 53,459 | $465,000 | 0.28% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 555,065 | $4,824,000 | 0.14% |